Cordio Medical raises $18M in Series C funding led by Peregrine Ventures and Ceros Financial Services

Peregrine portfolio company Cordio Medical raised $18 million in Series C funding, led by Peregrine Ventures and Ceros Financial Services.

The investment will support clinical studies, strategic partnerships, operations and R&D for Cordio’s HearO® platform, which uses speech signal processing and artificial intelligence to remotely monitor patients with congestive heart failure (CHF).

HearO analyzes changes in a patient’s voice to detect fluid accumulation associated with worsening heart failure, enabling earlier identification of deterioration and potential clinical intervention.

Official announcement: Cordio Medical